Osteoporosis Secondary Clinical Trials
2 recruiting trials for Osteoporosis Secondary. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Osteoporosis Secondary clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Regina Elena Cancer Institute (1), Ankara Etlik City Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Group 1: calcium carbonate/cholecalciferol (dietary_supplement, 1 trial), followed by Group 2: Synostea® (calcium carbonate/cholecalciferol/vitamin K/α-lactalbumin/ d-chiro-inositol), physical examination.
Track Osteoporosis Secondary trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
In women with breast cancer undergoing adjuvant hormone therapy, the marked tissue hypoestrogenism induced by therapy with aromatase inhibitors and/or tamoxifen ± GnRH analogues...
Deep Learning for Musculoskeletal Complications in Breast Cancer
Survival after breast cancer has increased due to early diagnosis and advances in treatment methods. Musculoskeletal problems related to cancer and its treatment constitute a...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Osteoporosis Secondary, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Osteoporosis Secondary, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Osteoporosis Secondary, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.